Financhill
Back

Freeport-McMoRan Vs. Axsome Therapeutics Industry Stock Comparison

Sell
26

FCX
Freeport-McMoRan

Last Price:
$32.91
Seasonality Move:
0.1%
Sell
40

AXSM
Axsome Therapeutics

Last Price:
$104.43
Seasonality Move:
22.19%
Sell
26
Freeport-McMoRan (FCX) is a Sell

Is Freeport-McMoRan a Buy, Sell or Hold?

  • The current Freeport-McMoRan [FCX] share price is $32.90. The Score for FCX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • FCX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Axsome Therapeutics (AXSM) is a Sell

Is Axsome Therapeutics a Buy, Sell or Hold?

  • The current Axsome Therapeutics [AXSM] share price is $104.46. The Score for AXSM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • AXSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FCX Stock Price Chart

What is Freeport-McMoRan's stock price today?

  • The Freeport-McMoRan share price today is $32.90
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FCX is experiencing slight selling pressure.

AXSM Stock Price Chart

What is Axsome Therapeutics's stock price today?

  • The Axsome Therapeutics share price today is $104.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing slight selling pressure.

FCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.53 Sell
Relative Strength Index (14 RSI): 43.16 Sell
Chaikin Money Flow: -2103758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.35 - 40.63) Sell
Bollinger Bands (100): (35.36 - 41.92) Sell

AXSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.89 Sell
Relative Strength Index (14 RSI): 41.94 Sell
Chaikin Money Flow: -208623 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (101.48 - 123.54) Sell
Bollinger Bands (100): (91.32 - 121.72) Sell

FCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.62 Buy
20-day SMA: 35.65 Sell
50-day SMA: 37.02 Sell
200-day SMA: 42.25 Sell
8-day EMA: 33.2 Sell
20-day EMA: 34.65 Sell
50-day EMA: 36.6 Sell
200-day EMA: 40.69 Sell

AXSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 101.15 Buy
20-day SMA: 109.42 Sell
50-day SMA: 118.5 Sell
200-day SMA: 97.31 Buy
8-day EMA: 103.33 Buy
20-day EMA: 107.82 Sell
50-day EMA: 111.25 Sell
200-day EMA: 99.58 Buy

Freeport-McMoRan Earnings Growth & FCX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $0.35 per share, and an increase next year of $0.54 per share.

Axsome Therapeutics Earnings Growth & AXSM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.66 per share, an increase next quarter of $0.34 per share, an increase this year of $1.79 per share, and an increase next year of $4.87 per share.

Freeport-McMoRan Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Axsome Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):